Open AccessEarly outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
Author(s) -
Dishank Patel,
Mira Desai,
Asha Shah,
R K Dikshit
Publication year - 2013
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.120170
Subject(s) - lamivudine , regimen , medicine , zidovudine , lopinavir , viral load , adverse effect , antiretroviral therapy , human immunodeficiency virus (hiv) , pediatrics , immunology , virus , viral disease , hepatitis b virus
Multi-drug resistance in treatment-experienced human immune deficiency virus (HIV) patients has been a major cause to first line antiretroviral therapy (ART) failure, necessitating a switch to second line therapy. In India, the second line treatment program is still relatively new with little experience and unclear outcomes. It is therefore, critical to assess the clinical, virological and immunological effectiveness and treatment outcome over the 1(st) year of follow-up in the patients' switched to the second line ART at public sector tertiary care center.